Lysosomes As Oxidative Targets for Cancer Therapy

Overview

Journal Oxid Med Cell Longev

Publisher Wiley

Specialties Cell Biology
Endocrinology

Date 2017 Aug 1

PMID 28757908

Citations 46

Authors

Rebecca F Dielschneider

Elizabeth S Henson

Spencer B Gibson

Affiliations

Soon will be listed here.

Abstract

Lysosomes are membrane-bound vesicles that contain hydrolases for the degradation and recycling of essential nutrients to maintain homeostasis within cells. Cancer cells have increased lysosomal function to proliferate, metabolize, and adapt to stressful environments. This has made cancer cells susceptible to lysosomal membrane permeabilization (LMP). There are many factors that mediate LMP such as Bcl-2 family member, p53; sphingosine; and oxidative stress which are often altered in cancer. Upon lysosomal disruption, reactive oxygen species (ROS) levels increase leading to lipid peroxidation, mitochondrial dysfunction, autophagy, and reactive iron. Cathepsins are also released causing degradation of macromolecules and cellular structures. This ultimately kills the cancer cell through different types of cell death (apoptosis, autosis, or ferroptosis). In this review, we will explore the contributions lysosomes play in inducing cell death, how this is regulated by ROS in cancer, and how lysosomotropic agents might be utilized to treat cancers.

Citing Articles

Atractylodin modulates ASAH3L to improve galactose metabolism and inflammation to alleviate acute lung injury.

Shi K, Xiao Y, Qu M, Xie Y, Wang Y, Ke C iScience. 2024; 27(10):110751.

PMID: 39351199 PMC: 11440247. DOI: 10.1016/j.isci.2024.110751.

Lysosome-Disrupting Agents in Combination with Venetoclax Increase Apoptotic Response in Primary Chronic Lymphocytic Leukemia (CLL) Cells Mediated by Lysosomal Cathepsin D Release and Inhibition of Autophagy.

Manivannan M, Yang X, Patel N, Peters A, Johnston J, Gibson S Cells. 2024; 13(12.

PMID: 38920669 PMC: 11202145. DOI: 10.3390/cells13121041.

Antitumor Efficacy of Arylquin 1 through Dose-Dependent Cytotoxicity, Apoptosis Induction, and Synergy with Radiotherapy in Glioblastoma Models.

Lieu A, Pan Y, Lee J, Hsieh Y, Lin C, Hsu Y Biomedicines. 2024; 12(4).

PMID: 38672261 PMC: 11048020. DOI: 10.3390/biomedicines12040907.

Molecular subtype identification and prognosis stratification based on lysosome-related genes in breast cancer.

Liu X, Sun K, Yang H, Zou D, Xia L, Lu K Heliyon. 2024; 10(4):e25643.

PMID: 38420434 PMC: 10900431. DOI: 10.1016/j.heliyon.2024.e25643.

The HN protein of Newcastle disease virus induces cell apoptosis through the induction of lysosomal membrane permeabilization.

Chen Y, Zhu S, Liao T, Wang C, Han J, Yang Z PLoS Pathog. 2024; 20(2):e1011981.

PMID: 38354122 PMC: 10866534. DOI: 10.1371/journal.ppat.1011981.

References

Eno C, Zhao G, Venkatanarayan A, Wang B, Flores E, Li C . Noxa couples lysosomal membrane permeabilization and apoptosis during oxidative stress. Free Radic Biol Med. 2013; 65:26-37. PMC: 3816129. DOI: 10.1016/j.freeradbiomed.2013.05.051. View

Schonberg D, Miller T, Wu Q, Flavahan W, Das N, Hale J . Preferential Iron Trafficking Characterizes Glioblastoma Stem-like Cells. Cancer Cell. 2015; 28(4):441-455. PMC: 4646058. DOI: 10.1016/j.ccell.2015.09.002. View

Akazawa Y, Mott J, Bronk S, Werneburg N, Kahraman A, Guicciardi M . Death receptor 5 internalization is required for lysosomal permeabilization by TRAIL in malignant liver cell lines. Gastroenterology. 2009; 136(7):2365-2376.e1-7. PMC: 2693420. DOI: 10.1053/j.gastro.2009.02.071. View

Nava V, Hobson J, Murthy S, Milstien S, Spiegel S . Sphingosine kinase type 1 promotes estrogen-dependent tumorigenesis of breast cancer MCF-7 cells. Exp Cell Res. 2002; 281(1):115-27. DOI: 10.1006/excr.2002.5658. View

Chen J, MURPHY T, Willingham M, Pastan I, August J . Identification of two lysosomal membrane glycoproteins. J Cell Biol. 1985; 101(1):85-95. PMC: 2113627. DOI: 10.1083/jcb.101.1.85. View

Medina D, Fraldi A, Bouche V, Annunziata F, Mansueto G, Spampanato C . Transcriptional activation of lysosomal exocytosis promotes cellular clearance. Dev Cell. 2011; 21(3):421-30. PMC: 3173716. DOI: 10.1016/j.devcel.2011.07.016. View

Kundra R, Kornfeld S . Asparagine-linked oligosaccharides protect Lamp-1 and Lamp-2 from intracellular proteolysis. J Biol Chem. 1999; 274(43):31039-46. DOI: 10.1074/jbc.274.43.31039. View

Zhang J, Zhou W, Lin J, Wei P, Zhang Y, Jin P . Autophagic lysosomal reformation depends on mTOR reactivation in H2O2-induced autophagy. Int J Biochem Cell Biol. 2015; 70:76-81. DOI: 10.1016/j.biocel.2015.11.009. View

Liu Y, Shoji-Kawata S, Sumpter Jr R, Wei Y, Ginet V, Zhang L . Autosis is a Na+,K+-ATPase-regulated form of cell death triggered by autophagy-inducing peptides, starvation, and hypoxia-ischemia. Proc Natl Acad Sci U S A. 2013; 110(51):20364-71. PMC: 3870705. DOI: 10.1073/pnas.1319661110. View

10.

Dixon S, Lemberg K, Lamprecht M, Skouta R, Zaitsev E, Gleason C . Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012; 149(5):1060-72. PMC: 3367386. DOI: 10.1016/j.cell.2012.03.042. View

11.

Sabella S, Carney R, Brunetti V, Malvindi M, Al-Juffali N, Vecchio G . A general mechanism for intracellular toxicity of metal-containing nanoparticles. Nanoscale. 2014; 6(12):7052-61. PMC: 4120234. DOI: 10.1039/c4nr01234h. View

12.

Roczniak-Ferguson A, Petit C, Froehlich F, Qian S, Ky J, Angarola B . The transcription factor TFEB links mTORC1 signaling to transcriptional control of lysosome homeostasis. Sci Signal. 2012; 5(228):ra42. PMC: 3437338. DOI: 10.1126/scisignal.2002790. View

13.

Zhitomirsky B, Assaraf Y . Lysosomes as mediators of drug resistance in cancer. Drug Resist Updat. 2016; 24:23-33. DOI: 10.1016/j.drup.2015.11.004. View

14.

Green D, Llambi F . Cell Death Signaling. Cold Spring Harb Perspect Biol. 2015; 7(12). PMC: 4665079. DOI: 10.1101/cshperspect.a006080. View

15.

Yagoda N, von Rechenberg M, Zaganjor E, Bauer A, Yang W, Fridman D . RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels. Nature. 2007; 447(7146):864-8. PMC: 3047570. DOI: 10.1038/nature05859. View

16.

Dielschneider R, Eisenstat H, Mi S, Curtis J, Xiao W, Johnston J . Lysosomotropic agents selectively target chronic lymphocytic leukemia cells due to altered sphingolipid metabolism. Leukemia. 2016; 30(6):1290-300. DOI: 10.1038/leu.2016.4. View

17.

Aits S, Jaattela M . Lysosomal cell death at a glance. J Cell Sci. 2013; 126(Pt 9):1905-12. DOI: 10.1242/jcs.091181. View

18.

Ryland L, Fox T, Liu X, Loughran T, Kester M . Dysregulation of sphingolipid metabolism in cancer. Cancer Biol Ther. 2011; 11(2):138-49. DOI: 10.4161/cbt.11.2.14624. View

19.

Mancias J, Wang X, Gygi S, Harper J, Kimmelman A . Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy. Nature. 2014; 509(7498):105-9. PMC: 4180099. DOI: 10.1038/nature13148. View

20.

Settembre C, Fraldi A, Medina D, Ballabio A . Signals from the lysosome: a control centre for cellular clearance and energy metabolism. Nat Rev Mol Cell Biol. 2013; 14(5):283-96. PMC: 4387238. DOI: 10.1038/nrm3565. View